Raymond Wang, M.D. is the Director of the Multidisciplinary Lysosomal Storage Disorder Program at CHOC and a board certified Clinical Geneticist and Biochemical Genetics Specialist. Dr. Wang is aware of the challenges faced by patients and families with rare diseases such as lysosomal storage disorders.

As an undergraduate, Dr. Wang attended Stanford University where he was a member of the Phi Beta Kappa honors society and graduated with a bachelor’s degree with Honors and Distinction in Biological Sciences. He earned his medical degree from the University of California, Los Angeles (UCLA) where he was a member of the Alpha Omega Alpha honors society. He completed his Internship and Residency in medical genetics and pediatrics at Cedars-Sinai Medical Center where he served as Chief Resident in his final year of training. Dr. Wang completed his fellowship in biochemical genetics at the UCLA Intercampus Medical Genetics Program.

Clinical Interests:

Lysosomal Storage Disorders, Mucopolysaccharidoses (MPS), Pompe Disease, Neuronal Ceroid Lipofuscinosis.

Research Focus:

Treating orthopedic manifestations of MPS, Cardiovascular disease in lysosomal storage disorders, Genomic therapies (gene therapy, CRISPR-gene editing).

Representative Publications:

Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type I

Treatment Reduces or Stabilizes Brain Imaging Abnormalities in Patients With MPS I and II

Carotid Intima-Media Thickness is Increased in Patients With Mucopolysaccharidoses

Clinical Course of Sly Syndrome (Mucopolysaccharidosis Type VII)

Share

Discuss in Social Wall

Share to rareTeam

Bookmark